Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
about
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
@en
type
label
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
@en
prefLabel
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
@en
P1050
P1476
Phase I Clinical Trial of Vori ...... With Advanced Multiple Myeloma
@en
P3098
NCT00111813
P4844
P580
2005-09-01T00:00:00Z
P582
2009-12-01T00:00:00Z